| An Open-Label, Multicenter, Multinational Study of the Safety, Efficacy and Pharmacokinetics of Asfotase Alfa (human recombinant tissue non-specific alkaline phosphatase fusion protein) in Infants and Children ≤ 5 Years of Age with Hypophosphatasia (HPP). |
Completed |
Asfotase Alfa |
2 |
ENB-010-10 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| Superiority of Insulin Glargine Lantus vs. NPH: Treat to Normoglycemia Concept.Effect of Insulin Glargine in Comparison to Insulin NPH in Insulin-nave People With Type 2 Diabetes Mellitus Treated With at Least One OAD and Not Adequately Controlled |
Completed |
Lantus® / Glimepiride / human insulin [NPH] |
3 |
LANTU_C_02762 |
King Fahad University Hospital (Al-Khobar), King Abdulaziz University Hospital (Jeddah) |
| Efficacy and Safety of Irbesartan/Amlodipine Fixed Combination Therapy Compared With Irbesartan Monotherapy in Hypertensive Patients Uncontrolled on Irbesartan 150 mg Monotherapy |
Completed |
Irbesartan Amlodipine |
3 |
IRBAM_R_04219 |
King Abdulaziz Medical City NG (Jeddah) |
| Efficacy and Safety of Long-Term (6 Months) Innohep® Treatment Versus Anticoagulation With a Vitamin K Antagonist (Warfarin) for the Treatment of Acute Venous Thromboembolism in Cancer Patients |
Completed |
Innohep (Tinzaparin) / Warfarin |
3 |
IN 0901 INT |
King Abdulaziz Medical City NG (Riyadh), King Fahad Specialist Hospital (Dammam), King Abdulaziz University Hospital (Jeddah), King Khalid University Hospital (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh) |
| Phase IIb Primary Vaccination Study to Evaluate Non-Inferiority & Persistence of the Immune Response of GSK Biologicals' MenACWY Conjugate Vaccine (Intramuscularly) vs Mencevax ACWY (Subcutaneously) to Healthy Subjects (11-55 Years of Age) |
Completed |
Meningococcal ACWY Conjugate Vaccine |
3b |
107402 |
King Abdulaziz Medical City NG (Riyadh) |
| Tocilizumab Efficacy and Safety in RA Patients After Inadequate Response to DMARDs or Anti-TNF |
Completed |
Tocilizumab |
3 |
ML22726 |
King Fahad Specialist Hospital (Dammam), King Fahad Medical City (Riyadh), King Abdulaziz University Hospital (Jeddah), Hira Hospital (Makkah) |
| An Open Label, Randomised Phase III Trial of BIBW 2992 and Vinorelbine Versus Trastuzumab and Vinorelbine in Patients With Metastatic HER2-overexpressing Breast Cancer Failing One Prior Trastuzumab Treatment |
Completed |
BIBW 2992 / Vinorelbine / Trastuzumab |
3 |
1200.75 |
King Fahad Medical City (Riyadh), International Medical Center (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah) |
| V212-001 A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients With Solid Tumor or Hematologic Malignancy |
Completed |
V212 |
3 |
V212-011 |
King Fahad Specialist Hospital (Dammam) |
| A Multicenter, Multinational, Extension Study to Evaluate the Long-Term Efficacy and Safety of BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) |
Completed |
BMN 110 |
3 |
MOR-005 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multinational Clinical Study to Evaluate the Efficacy and Safety of 2.0 mg/kg/Week and 2.0 mg/kg/Every Other Week BMN 110 in Patients With Mucopolysaccharidosis IVA (Morquio A Syndrome) |
Completed |
BMN 110 |
3 |
MOR-004 |
King Faisal Specialist Hospital and Research Center (Riyadh) |
